DIANOGEN, a privately owned company with headquarters in Huenenberg near Zug in Switzerland, is a technology specialist in the field of magnetic and non-magnetic micro- and nanoparticles (beads) and high-tech polymer modification.

Our scientific portfolio also includes cutting-edge new approaches in medical therapy (e.g. AIDS therapy, tumor therapy) using contactless controllable drug carriers. DIANOGEN's aim is to further develop and commercialise its biomedical/nanobiotechnology portfolio which has been built-up during the past 20 years. These technologies can be sold, licensed-out or further developed/joint development with industrial and/or financial partners.

Unique selling points of DIANOGEN's technology/products in comparison to established technologies/products are the following aspects:

• Synthesis within minutes (main competitors: 15-40 hrs)
  â–º cost and personnel saving
• Selectable polymer types (main competitors: mostly one product, e.g. polystyrene, silica gel)
  â–º better application optimisation
• Number of adaptable product and process parameters (main competitors: one major process procedure)
  â–º customised products easily achievable
• Sizes adaptable from 50 nm to 3,000 μm (main competitors: offer standard sizes 50 -100 nm, 0.5 to 1 μm or 1- 4 μm)
  â–º better application adaptation and extended application spectrum

DIANOGEN develops and offers innovative scientific/technological know how in the following areas:

• AIDS Therapy
• Biocompatible Polymers/Gels for Medical Implants or Wound Dressing
• Biopolymers / Hydrogels / Plastics for Bioscience and Medicine
• Carriers/Matrices for (Stem) Cell Immobilisation, Separation and Cultivation
• Cryopreservation
• Diagnostics
• Magnetic/Non-Magnetic Polymer Carriers / Beads
• Nanotechnology
• Radiation Technology for Polymer/Plastic Modification
• Tumor Therapy

DIANOGEN is looking for investors to strengthen its research and development activities.